Biodistribution of cisplatin revealed by imaging mass cytometry identifies extensive collagen binding in tumor and normal tissues

• DOI: 10.1038/srep36641
• Publication Date: 2016-11-04T10:04:52Z
• Authors: Qing Chang; Olga I. Ornatsky; Iram Siddiqui; Rita Straus; Vladimir I. Baranov; David W. Hedley
• Keywords: 0303 health sciences; Antineoplastic Agents; Mice, SCID; Xenograft Model Antitumor Assays; Article; 3. Good health; Pancreatic Neoplasms; Mice; 03 medical and health sciences; Animals; Humans; Tissue Distribution; Collagen; Cisplatin

AbstractImaging mass cytometry was used for direct visualization of platinum localization in tissue sections from tumor and normal tissues of cisplatin-treated mice bearing pancreas cancer patient-derived xenografts. This recently-developed technology enabled simultaneous detection of multiple markers to define cell lineage, DNA damage response, cell proliferation and functional state, providing a highly detailed view of drug incorporation in tumor and normal tissues at the cellular level. A striking and unanticipated finding was the extensive binding of platinum to collagen fibers in both tumor and normal mouse tissues. Time course experiments indicated the slow release of stroma-bound platinum, although it is currently unclear if released platinum retains biological activity. Imaging mass cytometry offers a unique window into the in vivo effects of platinum compounds, and it is likely that this can be extended into the clinic in order to optimize the use of this important class of agent.